Tuesday, November 6, 2018

Eli Lilly and Co said on Monday that its top-selling diabetes drug Trulicity significantly reduced the risk of heart attack, stroke and heart-related death in a broad range of people with type 2 diabetes, according to results of a large clinical trial.


from Reuters: Health News https://ift.tt/2D3DQYI

Related Posts:

  • LATEST HEALTH NEWSBayer shares continued to fall on Tuesday after a California jury on Monday awarded more than $2 billion in damages to a couple who alleged that the company's glyphosate-based weed killer Roundup caused their cancers. fr… Read More
  • LATEST HEALTH NEWS(Reuters Health) - People having surgery may be more likely to experience cardiovascular problems afterward when they have a common nighttime breathing disorder known as sleep apnea, a study suggests. from Reuters: Healt… Read More
  • LATEST HEALTH NEWS(Reuters Health) - Informal care for older relatives continues to affect the labor market, and the effects remain gendered, according to a new study in Canada. from Reuters: Health News https://reut.rs/2JkmhYn … Read More
  • LATEST HEALTH NEWSA California jury on Monday awarded more than $2 billion to a couple who claimed Bayer AG's glyphosate-based Roundup weed killer caused their cancer, in the largest U.S. jury verdict to date against the company in litigation … Read More
  • LATEST HEALTH NEWSBayer shares fell by as much as 5 percent on Tuesday after a California couple were awarded more than $2 billion in the largest U.S. jury penalty over allegations its Roundup weed killer causes cancer. from Reuters: Heal… Read More

0 comments:

Post a Comment

Followers

Contact Form

Name

Email *

Message *

Popular Posts

FOLLOW BY EMAIL

Enter your email address:

Delivered by FeedBurner